Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-495377
Filing Date
2016-03-07
Accepted
2016-03-07 17:02:46
Documents
141
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d121715d10k.htm 10-K 1933793
2 EX-21.1 d121715dex211.htm EX-21.1 4585
3 EX-23.1 d121715dex231.htm EX-23.1 2716
4 EX-23.2 d121715dex232.htm EX-23.2 2554
5 EX-31.1 d121715dex311.htm EX-31.1 9637
6 EX-31.2 d121715dex312.htm EX-31.2 9682
7 EX-32.1 d121715dex321.htm EX-32.1 4592
14 GRAPHIC g121715g15i62.jpg GRAPHIC 106703
  Complete submission text file 0001193125-16-495377.txt   12307833

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT sgnt-20151231.xml EX-101.INS 2766583
9 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20151231.xsd EX-101.SCH 94079
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20151231_cal.xml EX-101.CAL 174494
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20151231_def.xml EX-101.DEF 451015
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20151231_lab.xml EX-101.LAB 812284
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20151231_pre.xml EX-101.PRE 722347
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-35144 | Film No.: 161489208
SIC: 2834 Pharmaceutical Preparations